永輝雲創退出投資海底撈(06862.HK)餐飲供應鏈公司
據內地《天眼查》網站顯示,近日蜀海(北京)供應鏈管理有限責任公司出現工商變更,永輝雲創科技有限公司退出投資人行列,新增股東太陽維斯塔有限公司、雨知控股有限公司、亭和明有限公司。
蜀海(北京)供應鏈管理有限責任公司成立於2014年6月,法定代表人為施永宏,註冊資本1.11億人民幣,經營範圍包括供應鏈管理、企業管理、投資管理、餐飲管理、銷售食用農產品等。施永宏為海底撈(06862.HK)四位創始人之一。而蜀海是海底撈投資的餐飲供應鏈公司。
永輝雲創科技有限公司則是永輝超市旗下新零售平台,定位是「供應鏈+科技」雙引擎驅動的生鮮新零售企業。旗下擁有超級物種、永輝生活、永輝生活·到家三大核心業態。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.